2GY Stock Chart & Stats
€5.85
€0.05(0.85%)
At close: 4:00 PM EST
€5.85
€0.05(0.85%)
Day’s Range― - ―
52-Week Range€4.96 - €8.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€874.44M
Enterprise Value€317.86K
Total Cash (Recent Filing)€41.28B
Total Debt (Recent Filing)€229.26B
Price to Earnings (P/E)16.9
Beta0.58
Next Earnings
Nov 18, 2026EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)72.45
Shares Outstanding127,323,135
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-2.94
Price to Book (P/B)0.85
Price to Sales (P/S)0.38
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.88
Revenue Forecast (FY)€2.06B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationHealthy operating and free cash flow provides internal funding for investment, debt service and shareholder returns. The increase in free cash flow is especially constructive because it shows the business can generate liquidity even when reported net income remains weak.
Recurring Consumables And ServicesThe installed base of meters, diagnostic instruments and healthcare equipment can support repeat consumable, maintenance and service purchases. This mix may improve customer retention and make revenue more durable than one-time equipment sales alone.
Solid Product EconomicsConsistent gross margins indicate that PHC retains meaningful economics across its medical-device, diagnostics and healthcare-equipment portfolio. Positive operating margins also show an underlying ability to produce profit before financing and other below-the-line pressures.
Bears Say
Near-breakeven Net ProfitabilityVery thin and inconsistent net profitability leaves limited protection against cost increases, financing expenses or weaker demand. The history of losses also suggests that positive operating earnings have not yet translated into durable shareholder-level returns.
Meaningful LeverageAlthough leverage has improved from prior years, debt remains high relative to equity and cash-flow coverage is limited. This constrains financial flexibility, increases sensitivity to interest and refinancing conditions, and may compete with investment in growth.
Weak Earnings GrowthLow single-digit revenue expansion indicates limited top-line momentum, while the sharper EPS decline points to pressure from costs, financing or other earnings items. Without stronger operating leverage, growth may not materially improve shareholder returns.
PHC Holdings Corp. News
2GY FAQ
What was PHC Holdings Corp.’s price range in the past 12 months?
PHC Holdings Corp. lowest stock price was €4.96 and its highest was €8.40 in the past 12 months.
What is PHC Holdings Corp.’s market cap?
PHC Holdings Corp.’s market cap is €874.44M.
When is PHC Holdings Corp.’s upcoming earnings report date?
PHC Holdings Corp.’s upcoming earnings report date is Nov 18, 2026 which is in 64 days.
How were PHC Holdings Corp.’s earnings last quarter?
PHC Holdings Corp. released its earnings results on Aug 06, 2026. The company reported €0.276 earnings per share for the quarter, beating the consensus estimate of €0.121 by €0.155.
Is PHC Holdings Corp. overvalued?
According to Wall Street analysts PHC Holdings Corp.’s price is currently Overvalued.
Does PHC Holdings Corp. pay dividends?
PHC Holdings Corp. does not currently pay dividends.
What is PHC Holdings Corp.’s EPS estimate?
PHC Holdings Corp.’s EPS estimate is 0.19.
How many shares outstanding does PHC Holdings Corp. have?
PHC Holdings Corp. has 127,323,135 shares outstanding.
What happened to PHC Holdings Corp.’s price movement after its last earnings report?
PHC Holdings Corp. reported an EPS of €0.276 in its last earnings report, beating expectations of €0.121. Following the earnings report the stock price went up 0.877%.
Which hedge fund is a major shareholder of PHC Holdings Corp.?
Currently, no hedge funds are holding shares in DE:2GY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PHC Holdings Corp.
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Technical Analysis
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―